Sage Therapeutics Inc (SAGE)
13.66
+0.08
(+0.63%)
USD |
NASDAQ |
Apr 26, 16:00
13.66
0.00 (0.00%)
After-Hours: 17:00
Sage Therapeutics Market Cap: 821.36M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 816.25M |
| April 24, 2024 | 841.49M |
| April 23, 2024 | 778.38M |
| April 22, 2024 | 774.78M |
| April 19, 2024 | 801.22M |
| April 18, 2024 | 783.49M |
| April 17, 2024 | 755.54M |
| April 16, 2024 | 939.47M |
| April 15, 2024 | 920.83M |
| April 12, 2024 | 928.05M |
| April 11, 2024 | 995.97M |
| April 10, 2024 | 988.76M |
| April 09, 2024 | 992.96M |
| April 08, 2024 | 997.77M |
| April 05, 2024 | 986.95M |
| April 04, 2024 | 996.57M |
| April 03, 2024 | 1.031B |
| April 02, 2024 | 1.037B |
| April 01, 2024 | 1.076B |
| March 28, 2024 | 1.126B |
| March 27, 2024 | 1.144B |
| March 26, 2024 | 1.119B |
| March 25, 2024 | 1.123B |
| March 22, 2024 | 1.155B |
| March 21, 2024 | 1.200B |
| Date | Value |
|---|---|
| March 20, 2024 | 1.183B |
| March 19, 2024 | 1.159B |
| March 18, 2024 | 1.164B |
| March 15, 2024 | 1.200B |
| March 14, 2024 | 1.191B |
| March 13, 2024 | 1.239B |
| March 12, 2024 | 1.223B |
| March 11, 2024 | 1.273B |
| March 08, 2024 | 1.328B |
| March 07, 2024 | 1.284B |
| March 06, 2024 | 1.270B |
| March 05, 2024 | 1.276B |
| March 04, 2024 | 1.309B |
| March 01, 2024 | 1.314B |
| February 29, 2024 | 1.291B |
| February 28, 2024 | 1.355B |
| February 27, 2024 | 1.365B |
| February 26, 2024 | 1.360B |
| February 23, 2024 | 1.323B |
| February 22, 2024 | 1.337B |
| February 21, 2024 | 1.334B |
| February 20, 2024 | 1.333B |
| February 16, 2024 | 1.399B |
| February 15, 2024 | 1.527B |
| February 14, 2024 | 1.548B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
755.54M
Minimum
Apr 17 2024
9.777B
Maximum
Jul 12 2019
3.286B
Average
2.553B
Median
Market Cap Benchmarks
| Biogen Inc | 30.43B |
| Perspective Therapeutics Inc | 933.20M |
| Vanda Pharmaceuticals Inc | 265.25M |
| ADMA Biologics Inc | 1.493B |
| Finch Therapeutics Group Inc | 3.854M |
Market Cap Related Metrics
| PS Ratio | 9.458 |
| PEG Ratio | -1.937 |
| Price to Book Value | 1.027 |
| Price | 13.66 |
| Earnings Yield | -66.23% |
| PEGY Ratio | -1.937 |